Translational Medicine Communications · 2017 · 10 citations · 41 references
MedicineImmunologyOncologyCancer ImmunologyChemotherapyMedical OncologyNutrition During Cancer CareOncology NutritionSupportive Care In CancerCancer-related MalnutritionDescriptive Statistics TablesImmune Function ImpairmentLymphocyte PhenotypingMicronutrient Deficiencies In CancerObservational Study AnalysisOxidative Stress In CancerVitamin C Supplementation
Lymphopenia commonly occurs in cancer patients and predicts poor prognosis. It is caused by radio- and chemotherapy, with malnutrition and treatment-related oxidative stress playing key roles in its pathogenesis. Tumour-related morbidity is reported to be associated with reduced plasma ascorbate, which is a key physiological antioxidant and essential factor in immune function. A prospective observational study was conducted on 48 cancer patients with lymphopenia (<1500/μL) to investigate the total lymphocyte count (TLC) during four weeks of elective adjuvant treatment with intravenous (iv) vitamin C 7.5 g (Pascorbin®7.5 g) once a week. TLC values at baseline (just prior to start of treatment) and after 4 weeks treatment were compared using descriptive statistics. After 4 weeks iv vitamin C 7.5 g, TLC increased by a mean of 211/μL (p = 0.0018). Subgroup analyses showed that, in patients with severe lymphopenia (n = 25) (TLC <1000/μL), the increase in TLC was greater with a mean rise of 368/μL (p = 0.0004), than in patients (n = 23) with an initial TLC of 1000–1500 (mean rise of 40/μL) (p = 0.6105). TLC increased by at least 240/μL in half of the patients with severe lymphopenia and by more than 610/μL in 25% of patients. Our data indicate that iv high-dose vitamin C treatment increases TLC, which strongly implies improvement of immune function, especially in patients with severe lymphopenia. Appropriately-powered, randomized, placebo-controlled trials of iv high-dose vitamin C are now needed to define more precisely its role in the treatment of cancer-related lymphopenia and how this impacts on the patients’ clinical prognosis.
41
Qi Chen, Michael Graham Espey, Murali C. Krishna et al. · Proceedings of the National Academy of Sciences · 2005 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +15
Jihye Yun, Edouard Mullarky, Changyuan Lu et al. · Science · 2015 · 910 citations
Medicine, Cancer Biology, Oncology +14
Criteria and Recommendations for Vitamin C Intake
Mark Levine · JAMA · 1999 · 557 citations